About Kumamoto University Hospital ( Site 2602)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
2
Clinical Trials at Kumamoto University Hospital ( Site 2602)
During the past decade, Kumamoto University Hospital ( Site 2602) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
2018-11-08
2024-09-28
Active, not recruiting
1,579
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
2018-12-27
2031-01-24
Active, not recruiting
1,240
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kumamoto University Hospital ( Site 2602)
According to Clinical.Site data, the most researched conditions in "Kumamoto University Hospital ( Site 2602)" are
"Breast Cancer" (1 trials) and "Stomach Neoplasms" (1 trials). Many other conditions were trialed in "Kumamoto University Hospital ( Site 2602)" in a lesser frequency.
Clinical Trials Intervention Types at Kumamoto University Hospital ( Site 2602)
Most popular intervention types in "Kumamoto University Hospital ( Site 2602)" are "Biological" (2 trials), "Drug" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-fluorouracil" (1 trials), "Cisplatin" (1 trials), "Cyclophosphamide (C)" (1 trials), "Doxorubicin (A)" (1 trials) and "Endocrine therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kumamoto University Hospital ( Site 2602)
The vast majority of trials in "Kumamoto University Hospital ( Site 2602)" are
2 trials for "All" genders.
Clinical Trials Status at Kumamoto University Hospital ( Site 2602)
Currently, there are NaN active trials in "Kumamoto University Hospital ( Site 2602)".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Kumamoto University Hospital ( Site 2602),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kumamoto University Hospital ( Site 2602), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".